13F Data
13F filer · CIK 1776382

venBio Partners LLC

SAN FRANCISCO, CA · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$519.4M
+$238.8M vs prior
Positions
7
New / sold out
2 / 1
Added / reduced
1 / 1
Turnover
1.0%
buys $182.9M · sells $4.0M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewPARABILIS MEDICINES INC+5,266,697–+$144.1M
NewACHIEVE LIFE SCIENCE INC+5,914,720–+$38.6M
AddedPHARVARIS N V+4,126+0.1%+$142.7K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outARTIVA BIOTHERAPEUTICS INC-531,337-100.0%$-3.4M
ReducedHARMONY BIOSCIENCES HLDGS IN-17,000-3.5%$-619.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $38.1MQ1 2019: $123.5MQ2 2019: $225.4MQ3 2019: $210.8MQ4 2019: $233.3MQ1 2020: $117.3MQ2 2020: $120.3MQ3 2020: $658.0MQ4 2020: $1.1BQ1 2021: $1.1BQ2 2021: $847.2MQ3 2021: $1.0BQ4 2021: $555.1MQ1 2022: $451.1MQ2 2022: $351.2MQ3 2022: $432.2MQ4 2022: $322.5MQ1 2023: $180.4MQ2 2023: $276.3MQ3 2023: $352.7MQ4 2023: $667.2MQ1 2024: $281.9MQ2 2024: $231.5MQ3 2024: $194.3MQ4 2024: $170.7MQ1 2025: $123.6MQ2 2025: $114.8MQ3 2025: $176.4MQ4 2025: $216.3MQ1 2026: $280.6MQ2 2026: $519.4M
Q4 2018Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PHARVARIS N VCOM4,643,430$160.6M30.92%
2PARABILIS MEDICINES INCCOM5,266,697$144.1M27.75%
3ALUMIS INCCOM4,528,408$127.4M24.53%
4ACHIEVE LIFE SCIENCE INCCOM5,914,720$38.6M7.44%
5ALX ONCOLOGY HLDGS INCCOM12,884,638$26.7M5.14%
6HARMONY BIOSCIENCES HLDGS INCOM472,194$17.2M3.31%
7LYELL IMMUNOPHARMA INCCOM NEW337,697$4.7M0.91%